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A B S T R A C T
Cilia are highly conserved and ubiquitously expressed organelles. Ciliary defects of genetic origins lead to ci-
liopathies, in which retinal degeneration (RD) is one cardinal clinical feature. In order to eﬃciently ﬁnd and
design new therapeutic strategies the underlying mechanism of retinal degeneration of three murine model was
compared. The rodent models correspond to three emblematic ciliopathies, namely: Bardet-Biedl Syndrome
(BBS), Alström Syndrome (ALMS) and CEP290-mediated Leber Congenital Amaurosis (LCA). Scotopic rodent
electroretinography (ERG) was used to test the retinal function of mice, Transmitted Electron microscopy
(T.E.M) was performed to assess retinal structural defects and real-time PCR for targeted genes was used to
monitor the expression levels of the major apoptotic Caspase-related pathways in retinal extracts to identify
pathological pathways driving the RD in order to identify potential therapeutic targets. We found that BBS and
CEP290-mediated LCA mouse models exhibit perinatal retinal degeneration associated with rhodopsin mis-
localization in the photoreceptor and the induction of an Endoplasmic Reticulum (ER) stress. On the other hand,
the tested ALMS mouse model, displayed a slower degeneration phenotype, with no Rhodopsin mislocalization
nor ER-stress activity. Our data points out that behind the general phenotype of vision loss associated with these
ciliopathies, the mechanisms and kinetics of disease progression are diﬀerent.
1. Introduction
Ciliopathies, a group of rare genetic diseases, can be either of non-
syndromic or syndromic nature in which retinal degeneration (RD) is a
cardinal clinical feature (Bujakowska et al., 2017; Estrada-Cuzcano
et al., 2012). Ciliopathies contain a spectrum of disorders ranging from
isolated RD such as in a sub group of Leber Congenital Amaurosis (LCA)
(i.e: Cep290), to complex syndromes with multiple organs dysfunction
such as, for example, Bardet-Biedl Syndrome (BBS), Alström Syndrome
(ALMS) and the lethal manifestations in the Meckel-Gruber syndrome
(Adams et al., 2007; Mockel et al., 2011; Waters and Beales, 2011).
These syndromes are caused by mutations in diﬀerent genes coding for
proteins with distinct roles and cellular localizations within the ciliated
cells (Cui et al., 2013; Estrada-Cuzcano et al., 2012; Knorz et al., 2010;
Reiter and Leroux, 2017). Interestingly, the retinal degeneration pre-
sents in many ciliopathies is often of early onset leading to severe visual
impairment but can exhibit variable progression phenotypes. For ex-
ample, RD is characterized by an initial photophobia with nystagmus in
Alström syndrome in the ﬁrst months of life, whereas the ﬁrst symp-
toms will be evident only after a few years with nyctalopia and visual
ﬁeld deﬁciency in BBS (Hamel, 2006; May-Simera et al., 2017). The fact
that such diﬀerences exist in the RD progression combined with the
myriads of mutated genes, lead us to hypothesize that there might be
diﬀerent mechanisms at play at the level of the photoreceptor cell in
these diﬀerent ciliopathies. In view of the heterogeneity, the large
number of genes and mutations involved in RD, identifying such me-
chanistic diﬀerences behind these retinal phenotypes is of prime im-
portance in order to properly stratify the patients with future appro-
priate therapy.
Currently, there is no treatment available for RD; one clinical trial
showed the eﬃcacy of gene therapy in LCA (Russell et al., 2017) but it
is speciﬁc of RPE65 gene mutations. The identiﬁcation of common
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mechanisms could allow the development of therapeutics applicable to
RD regardless of the aﬀected gene and the type of mutation. RD in the
ciliopathies is linked to the structure of the photoreceptor itself. The
photoreceptors outer segment is connected to the inner segment via the
connecting cilium (May-Simera et al., 2017; Sjostrand, 1953). This
connecting cilium is a protein highway that allows the eﬃcient con-
nection between the biosynthetic active inner segment and the light
detecting outer segment for the visual process to start upon photonic
impulse. In ciliopathies, ciliary proteins are defective and therefore are
no longer able to play their respective roles in the photoreceptor. One of
the commonly associated mechanism to photoreceptor apoptosis in the
ciliopathies is a defective intraﬂagellar transport (IFT) of proteins be-
tween the two segments (Wright et al., 2010). This defect ultimately
causes protein accumulation in the IS, which in turn triggers a pro-
apoptotic unfolded protein response (UPR) associated with an ER-stress
(Mockel et al., 2012; Starr et al., 2018). Previously, we have proved that
UPR activation occurs in a Bbs12 model, leading us to develop a
pharmacological approach (GIVin). The treatment slowed RD in our
mouse model (Mockel et al., 2012). Other studies targeting non-cilio-
pathy models have also shown that UPR is an interesting pathway to
target in slow RD presenting ER stress. However, RD mechanisms for
other emblematic ciliopathies still need to be characterized. We
therefore used mice models for three iconic ciliopathies namely BBS,
LCA (CEP290) and ALMS to analyze and compare their respective ret-
inal phenotypes while measuring the key components of the UPR
pathway.
To date 21 genes (BBS1-BBS21) have been identiﬁed in BBS (Heon
et al., 2016). Half of these proteins are involved in two major BBS
protein complexes, the Bbsome complex containing 7 of the BBS pro-
teins (BBS1, 2, 4, 5, 7, 8 and 9) (Nachury et al., 2007) and the BBS-
chaperone complex containing three BBS proteins (BBS 6, 10 and 12)
(Seo et al., 2010). The pro-apoptotic mechanism of RD associated with
Bbs12 has already been characterized in a mouse model (Mockel et al.,
2012) and apoptosis was shown to be induced by a deleterious protein
accumulation in the IS, leading to the activation of the UPR pathways.
We, therefore, determined whether the other BBS proteins could induce
the same type of events leading to RD. In the LCA model we studied the
centrosomal protein 290 (CEP290), also known as the LCA10 protein,
mutations in this gene may lead to various ciliopathies and remarkably
a recurrent mutation in intron 26 of CEP290 is a frequent cause of LCA
(Garanto et al., 2015). CEP290 protein is known to be involved in
photoreceptor development and when mutated leads to early-onset
retinal degeneration (Garanto et al., 2015). Finally, in ALMS, only one
gene (ALMS1) has been identiﬁed to date. In human patients, ALMS is
characterized by early onset cone-rod dystrophy leading to blindness
but the mechanism behind this phenotype remains elusive (Marshall
et al., 2007).
2. Material and methods
2.1. Generation of knockout mice and animal husbandry
All experimental procedures were approved by the local ethical
committee of Strasbourg University. Bbs1M390R/M390R (henceforth
Bbs1−/−), Bbs10−/−, Cep290−/−and Almsfoz/foz mice with their control
wild type littermates were generated as described previously (Arsov
et al., 2006; Cognard et al., 2015; Davis et al., 2007; Mockel et al.,
2012). Stock Cep290tm1.1Jgg/J mice were developed by replacing exons
36, 37 (schematic representation of the mutated allele in
Supplementary Fig. 1). Relevant mouse models were bred on a C57BL/
6N background and crossbreeding with the C57BL/6J strain to remove
the strain-associated interfering Rd8 mutation which interferes with the
retinal phenotype (Mattapallil et al., 2012). Mice were kept and bred in
humidity- and temperature-controlled rooms on a 12 h light/dark cycle
on normal chow and water ad libitum. PCR-genotyping were carried out
using KAPA Mouse Genotyping Kit (Catalog#KK7302, Kapa Biosystems,
Woburn, Massachusetts, USA), primers used for genotyping are listed in
Table 1 in supplementary data.
2.2. Electroretinogram
Electroretinograms (ERGs) were performed at the indicated time
points with the HMsERG system (Ocuscience®, Kansas City, Missouri,
USA). Mice were dark-adapted overnight and then anesthetized by in-
traperitoneal injection of Domitor® (Medetomidine, 7.6 μg/g body
weight) and Ketamine (760 μg/g body weight). The experiments were
carried out in dim red light (Catalog #R125IRR, Philips, Suresnes,
France). ERGs standard procedure was used according to manufac-
turer's protocol (Ocuscience®, Kansas City, Missouri, USA). Brieﬂy, the
protocol consisted in recording a dark-adapted ERG (Scotopic ERG)
after photonic stimuli with intensities ranging from 0.1 to 25 cd s/m2.
ERG results were ampliﬁed and captured digitally by ERG View system
4.3 (Ocuscience®, Kansas City, Missouri, USA). The a-wave (corre-
sponding to the ﬁrst negative deﬂection) for the scotopic responses was
recorded and analyzed.
2.3. Histology and immunoﬂuorescence
Eyeballs were harvested after ERG examination and were ﬁxed 1 h
in 4% formalin (Catalog#F5554-4L, Sigma-Aldrich, Saint-Louis,
Missouri, USA) at 4 °C, and then incubated sequentially in 10%, 20%
and 30% sucrose solutions for 1 h. Eyeballs were then transferred into
Optimal Cutting Temperature Compound™ (OCT™, Catalog# 4583,
Tissue-Tek® OCT™, Sakura® Finetek, Torrance, California, USA) and
frozen in liquid nitrogen. 7 μm cryosections were cut with Cryostat
Leica CM1950 (Catalog# 14 0477 8001, Leica Biosystems, Wetzlar,
Germany). Eye sections were treated for Haematoxylin-Eosin staining.
The thickness of photoreceptor (ONL), inner nuclear layer (INL), outer
Table 1
Primers for genotyping PCR.
Gene Oligo name Sequence(5′-3′)
Bbs10 4054 ACA AAT ACA ATT GAT CAT CGA TGT G
Bbs10 4057 ACC TCC CCA CTT GAA CGA GGT CT
Bbs10 4058 GTT GCC TGG CTT GGG TGG CA
Cep290 M11336 TGG AAG ACC AGG CTT CAG AG
Cep290 M11340 GGC TCA CTG TGA TCT TGT GC
Cep290 W11338 GTA AGT GCC CGA CAG CTA CC
Cep290 W11339 AGC GCA GTG CAG AGT ATG TG
Rd8 F1 GTGAAGACAGCTACAGTTCTGATC
Rd8 R GCCCCATTTGCACACTGATGAC
Rd8 F2 GCCCCTGTTTGCATGGAGGAAACTTGGAAGACAGCTACAGTTCTTCTG
Alms Forward ACA ACT TTT CAT GGC TCC AGT
Alms Reverse TTG GCT CAG AGA CAG TTG AAA
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segment (OS) and inner segment (IS) were measured ﬁve times at
100 μm regular intervals, the ﬁrst one was measured at 500 μm distance
from the optic nerve. For immunoﬂuorescence, cryosections were post-
ﬁxed in 4% formalin for 3min and then permeabilized with 0.01%
TritonX-100 in PBS (Catalog #ET330, Euromedex, France) for 5min.
Sections were incubated 30min in 1%BSA (Catalog #A7030-100G,
Sigma-Aldrich, USA) in PBS at room temperature, then incubated
overnight with primary antibodies diluted in blocking buﬀer at 4 °C.
Sections were then incubated for 1 h at room temperature with the
secondary antibody. Nuclei were counterstained with Hoechst
(#D1306, Invitrogen, Carlsbad, California, USA). Slices were then
mounted with Vectashield® Mounting Medium (Catalog #H-1000,
Vector Laboratories, Burlingame, California, USA). Images were ac-
quired on a Leica SP8 confocal microscope with either a HC PL APO CS2
63x/1.40 or 40x/1.30 oil immersion lens, driven by the LAS X software
(Leica, Weitzlar, Germany). Antibodies used are listed in Table 2 in
supplementary data.
2.4. Transmission electron microscopy (T.E.M.)
The samples were ﬁxed by immersion in 2.5% Glutaraldehyde and
2.5% Para-formaldehyde in Cacodylate buﬀer (0.1M, pH 7.4), post
ﬁxed in 1% osmium tetroxide in 0.1M Cacodylate buﬀer for 1 h at 4 °C
and then dehydrated through graded alcohol (50, 70, 90, 100%) and
propylene oxide for 30 min each. Samples were embedded in Epon™
812 (Sigma-Aldrich, Saint-Louis, Missouri, USA). Semi-thin sections
were cut at 2 μm with an ultra-microtome (Leica Ultracut UCT, Leica
Biosystems, Wetzlar, Germany) and stained with Toluidin blue, and
histologically analyzed by light microscopy. Ultrathin sections were cut
at 70 nm and contrasted with uranyl acetate and lead citrate and ex-
amined at 70 kV with a Morgagni 268D electron microscope. Images
were captured digitally by Mega View III camera (Soft Imaging System).
The thickness of the photoreceptor ONL, INL and OS + IS were mea-
sured ﬁve times at 100 μm regular intervals on Toluidin blue stained
sections, 3 mice were used for per genotype. Nuclei of ONL were
counted, on Toluidin blue stained sections. At least 20 rows were
counted in each section and 3 eyes were used for each genotype.
2.5. RNA extraction and real-time PCR
Retinal tissues were harvested as previously described (Mockel
et al., 2012). RNA extraction was performed using Trizol® reagent
(Catalog #15596-018, Invitrogen®, Life Technologies™, Carlsbad, Cali-
fornia, USA) and Tissue Ruptor® (Catalog #9001272, Qiagen, Venlo,
Nederland). RNA samples were treated with DNase (TURBO™ DNA-free
Kit, Catalog #AM1907, Ambion®, Life Technologies™, Carlsbad, Cali-
fornia, USA) prior to reverse transcription using the iScript® cDNA
synthesis kit (Catalog#170–889, BioRad, USA). Self-design primers
were purchased from Sigma-Aldrich. Quanti-tech Primers were pur-
chased from Qiagen, Courtaboeuf, France (Table 3). Real-Time PCR was
performed using the iQ SYBR® Green Supermix (Catalog#170–8886,
BioRad, USA) on C1000TM thermo-cycler (CFX96, Real-Time System,
Bio-Rad, USA). Real-time PCR was carried out according to the fol-
lowing cycle: initial hold at 95 °C for 30 s and then 39 cycles at 95 °C for
5s and 60 °C for 30s. Quantitative gene expression was calculated by the
2ΔΔCt method relative to the reference gene, Gapdh. Primers used for
real-time PCR are listed in Table 3 in supplementary data.
2.6. Organotypic culture
The retinas were transferred, with retinal pigmented epithelium side
down, to a nitrocellulose culture membrane (catalogue number
PICMORG50; Millipore, Molsheim, France) and cultivated as previously
described (Mockel et al., 2012). Speciﬁc gene silencing with lenti-
viruses that carried a shRNA sequence for Alms1 (catalogue numbers sc-
108080 (Ctl), sc-72345-V (Alms1)); Santa Cruz Biotechnology, Tebu
Bio, Yvelines, France) was performed by adding 20 μl of a viral sus-
pension containing 105 infectious units to the culture medium over-
night. The infected explants were then washed and cultured for 3 days,
with half the medium refreshed daily. Explants were not maintained
longer in culture to avoid unspeciﬁc apoptosis in the diﬀerent retinal
layers.
2.7. Statistical analysis
Student's t-test (two-tailed) was applied to all data (two samples).
Statistical tests were performed using GraphPad/Prism version 5. All
data in bar charts show mean ± SEM. p < 0.05 is considered to have
signiﬁcant diﬀerences.
3. Results
3.1. Bbs classical retinal apoptotic phenotype
To assess if mutations in other BBS proteins were inducing RD
through the same pro-apoptotic pathophysiological mechanism as the
one associated with Bbs12 (Mockel et al., 2012), two BBS models,
Bbs10−/− mice model and Bbs1 M390R/M390R mice model have been
characterized and compared. The retinal phenotype for Bbs1 M390R/
M390R has been previously characterized (Davis et al., 2007). In both
mice models, histology and RNA analysis were performed on 14-days-
old retinas and ERG were performed on 3-month-old mice. 3-month-old
Bbs10−/− mice showed a signiﬁcant decrease in light detection capa-
city measured by ERG compared to control mice (Fig. 1A). Toluidin-
blue staining showed that 14-days-old Bbs10−/− retina present a sig-
niﬁcant reduction of the retinal thickness in IS, OS, ONL and INL
compared to wild type mice (Fig. 1B, Supplementary Fig. 2A) associated
to a decreased of the number of ONL nuclei (Supplementary Fig. 2A).
The outer and inner segments of the photoreceptors are completely
disorganized but with a correctly formed axonemal microtubules in the
connecting cilium as observed by T.E.M (Fig. 1B, Supplementary
Fig. 2B) and previously described in Bbs10−/− mice (Cognard et al.,
2015) and in other BBS mouse models (Davis et al., 2007; Dilan et al.,
2018; Hsu et al., 2017; Mockel et al., 2012). In 14-days-old Bbs10+/+
control retinas, rhodopsin was localized in the OS, while rhodopsin is
mislocalized in the IS and the ONL in Bbs10−/− retinas (Fig. 1C,
Supplementary Fig. 2C). The mRNA levels of key UPR proteins were
Table 2
Antibodies used.
Antibodies Catalog Company
Rhodopsin mouse monoclonal MAB5316 Chemicon
Goat-anti mouse Alexa Fluor® 594 A-11032 Invitrogen
Table 3
Primers used for real-time PCR.
Gene Reference Company
Mu-Bbs10-Rt-F1 TGCTTAGCAGGGATGGAG Sigma-Aldrich
Mu-Bbs10-Rt-R1 TTGCAGAGCCTGGGAAATAG Sigma-Aldrich
Alms1 F CTGATTTGCCTTTGCTGACA Sigma-Aldrich
Alms1 R GCCCTCTGTAAGTGGATGC Sigma-Aldrich
Caspase3 Mm_Casp3_2_SG QT01164779 Qiagen
Caspase6 Mm_Casp6_2_SG QT00494921 Qiagen
Caspase7 Mm_Casp7_1_SG QT01058085 Qiagen
Caspase9 Mm_Casp9_1_SG QT00133280 Qiagen
Caspase12 Mm_Casp12_2_SG QT00495376 Qiagen
Bip Mm_Hspa5_1_SG QT00172361 Qiagen
Chop10 Mm_Ddit3_2_SG QT01749748 Qiagen
Perk Mm_Eif2ak3_1_SG QT00147329 Qiagen
Gapdh Mm_Gapdh_3_SG QT01658692 Qiagen
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measured in 14-day-old Bbs10−/− mice retinas. Endoplasmic reticulum
(ER) stress genes such as Bip and Perk, are signiﬁcantly increased in
Bbs10−/− mice retinas. Caspase 12 along with other caspase eﬀectors
like Caspase 3 and Caspase 6 are also signiﬁcantly increased (Fig. 1D).
Similarly, we characterized the Bbs1 −/− mice to conﬁrm the UPR
activation as a common mechanism in BBS models. The Bbs1−/−mouse
model (Davis et al., 2007) exhibits similar retinal degeneration as the
other tested BBS model (Bbs10 and 12) (Mockel et al., 2012). The UPR-
related set of genes was also upregulated in the 14-day-old Bbs1 M390R/
M390R retina (Fig. 1E) as in Bbs10−/− retina. These data indicate that
the inactivation of the BBS1 protein of the Bbsome triggers the same
pro-apoptotic pathway as BBS10.
3.2. LCA-Cep290-mouse model shares the same pro-apoptotic, UPR-
mediated mechanism with the Bbs
To verify if this LCA mouse model could share the same pro-apop-
totic mechanism as BBS as part of the ciliopathy family, the same ex-
perimental approach than BBS was used. At 1-month-old, no ERG signal
was detected in Cep290−/− mice. (Fig. 2A). Histological studies at 14
postnatal days on Toluidin-blue stained sections showed a disruption
and thinning of retinal layers (IS/OS and ONL) in the Cep290−/− retina
Fig. 1. Retinal phenotype and molecular characterization of Bbs10 and Bbs1 mice.
A) Scotopic ERG of 3-month-old Bbs10 mice (n = 5), *: P≤ 0.05; B) Toluidin blue staining (Scale bar: 100 μm) and transmission electron microscope (T.E.M) (Scale
bar: 10 μm) of 14-day-old Bbs10 mice retinas (n=3). RPE: Retinal Pigment Epithelium, OS: Outer Segment: IS: Inner segment, ONL: Outer Nuclear Layer, INL: Inner
Nuclear Layer; C) Immunoﬂuorescence of rhodopsin (red) and counterstained nuclei in DAPI on 14-day-old Bbs10 mice.(n=3) (Scale bar: 40 μm); D) Stress genes
normalized fold expression (NFE) in 14-day-old Bbs10 mice (n = 3), *: P ≤ 0.05; E) Stress genes NFE in 14-day-old Bbs1 mice (n = 3), *: P ≤ 0.05. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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(Fig. 2B, Supplementary Fig. 3A). A decrease of nuclei number in the
ONL of Cep290−/− retina has been observed but it was not statistically
signiﬁcant. T.E.M. analysis revealed the presence of a normal axomal
microtubules of the connecting cilium without intact photoreceptors
outer segment (Fig. 2B, Supplementary Fig. 3B), which correlates with
no ERG signal in Cep290−/− mice. On 14-day-old Cep290+/+ control
retinas, immunostaining for rhodopsin showed that rhodopsin localizes
in the OS. In contrast, on 14-day-old Cep290−/− retinas, rhodopsin was
observed in the limits between IS and ONL and in the ONL (Fig. 2C,
Supplementary Fig. 3C). The exact location is complicated pinpoint as
the IS and OS are severely decreased. At this same age, an upregulation
of key genes of the UPR pathway namely Bip, Chop10, Perk and Cas-
pase12 (Fig. 2D) is also observed in the retinas of Cep290−/− mice.
3.3. Alms1 foz/foz retinal degeneration phenotype
Next, we focused on the retinal phenotype associated with the ALMS
syndrome. We investigated the retinal phenotype in the spontaneous
mutant mouse line, the Fattie Aussie mouse (Alms1foz/foz) (Arsov et al.,
2006). Interestingly, the ERG measurements in 1-month-old Alms1foz/foz
mice did not present any signiﬁcant attenuation of scotopic ERG
responses compared to wild type mice at the same age (Fig. 3A). The
ERGs were consistent with the retinal morphology; no diﬀerence in
retinal thickness was observed in 1-month-old Alms1foz/foz versus con-
trol Alms1+/+ on retinas H&E staining (Fig. 3B and C). On the other
hand, ﬂat electroretinograms were obtained in 1-year-old Alms1foz/foz
(Fig. 3D), suggesting a slow degenerative process of the retina. Con-
comitantly, signiﬁcant thinning of the IS/OS and ONL was measured in
1-year-old Alms1foz/foz (Fig. 3E and F). In order to identify any temporal
tipping point in the ALMS-related retinal phenotype, we monitored the
a-wave amplitude of scotopic ERGs, through time over a 9-month
period (Fig. 3G). Interestingly, the a-wave amplitude of the Alms1foz/foz
rapidly decreased through time. By plotting the a-wave amplitude
evolution for the two genotypes, we identiﬁed an intersecting point at 7
weeks. We thus started focusing on the Alms1foz/foz retinas at 7 weeks
postnatal. T.E.M analysis of the Alms1foz/foz photoreceptors revealed
swelling of the IS together with the presence of vacuoles in the cyto-
plasm as indicated by asterisks (Fig. 4A) and an intact axonemal
structure of the connecting cilium in photoreceptors (Supplementary
Fig. 4A). Rhodopsin transport was maintained in Alms1foz/foz retina, as
rhodopsin was primarily detected in the OS of the photoreceptor
(Fig. 4B, Supplementary Fig. 4B). Real-time PCR on the 7-week-old
Fig. 2. Retinal phenotype and molecular characterization of Cep290−/− mice.
A) Scotopic ERG of 1-month-old Cep290 mice (n=3); B) Toluidin blue staining (Scale bar: 100 μm) and T.E.M (Scale bar: 2 μm) of 14-day-old Cep290 mice retinas.
(n=3) OS: Outer Segment: IS: Inner segment, ONL: Outer Nuclear Layer, INL: Inner Nuclear Layer, CC: Conecting Cilium; C) Immunoﬂuorescence of rhodopsin (red)
and counterstained nuclei in DAPI on 14-day-old Cep290 mice.(n=3) (Scale bar: 40 μm).). The space between the RPE and the OS is due a detachment of the RPE
during preparation.; D) Stress genes NFE in 14-day-old Cep290mice retinas *: P≤ 0.05. (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the Web version of this article.)
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retinas for the key UPR genes did not show any signiﬁcant diﬀerence in
expression level in Alms1foz/foz (Fig. 4C) suggesting that the associated
phenotype was not linked to the UPR pathways.
Next, we used the organotypic culture approach and culture 14-day-
old WT retinas to knock-down Alms1 using a lentiviral approach as
previously performed (Mockel et al., 2012). 3 days post-infection, real-
time PCR analysis showed a 40% decrease in Alms1 expression level
(Fig. 4D) with no diﬀerence in expression level of the key UPR-related
genes (Fig. 4E) as expected without total absence of Alms1. The ALMS-
mediated retinal degeneration in the Alms1foz/foz mice is not primarily
UPR-related.
4. Discussion
RD associated with ciliopathies leads to major visual impairment
and understanding the underlying pathogenesis is a prerequisite to
deﬁne therapeutic options. Describing the pro-apoptotic mechanism
underlying ciliopathy-related RD will help to design the therapeutic
agents that could hamper the degeneration. With this aim, we studied
diﬀerent murine models for three emblematic ciliopathies, and
Fig. 3. Retinal phenotype and mole-
cular characterization of Alms1foz/foz
mice.
A) Scotopic ERGs recording showed
retinal function of Alms1+/+ and
Alms1foz/foz mice at 1 month-old. B&C).
H&E staining (Scale bar: 50 μm) and
retinal thickness measurement of 1
month-old Alms1+/+ and Alms1foz/foz
mice retinas (n=3) OS: Outer
Segment: IS: Inner segment, ONL: Outer
Nuclear Layer, INL: Inner Nuclear
Layer; D) Scotopic ERGs recording
showed retinal function of Alms1+/+
and Alms1foz/foz mice at 1-year-old. E&
F) H&E staining (Scale bar: 50 μm) and
retinal thickness measurement of 1-
year-old Alms1+/+ and Alms1foz/foz
mice retinas (n = 3), *: P ≤ 0.05. G)
Evolution of the ERG a-wave amplitude
as a function of age for Alms1+/+ and
Alms1foz/foz mice.
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interestingly we could diﬀerentiate between UPR-related RD, including
the Cep290-LCA and three tested BBS mouse models, and non-UPR-
related RDs, namely the ALMS mouse model. Interestingly, the pro-
gression rate and the severity of the retinal phenotype in these diﬀerent
mouse models of ciliopathies might be related the UPR pathway as
indeed the two UPR-related ciliopathies (BBS and LCA) showed a faster
retinal degeneration compared to the ALMS UPR-independent cilio-
pathies.
Our results showed that, associated to Rhodopsin traﬃcking defect,
key components of the ER stress response were upregulated on the
transcriptional level that depicts a common mechanism linked to retinal
degeneration in BBS syndromes and LCA, the Bbs1 M390R/M390R mice,
Bbs10−/− mice and Cep290−/− mice models used herein; although
further studies are required to verify this impact on the post-
transcriptional level. These mechanisms were also present in Bbs12−/−
mice model, in the Rd16 mouse model; a LCA mice model (Mockel
et al., 2012; Starr et al., 2018). In Bbs4−/− mice models ER stress has
not been reported to date even though a Rhodopsin traﬃcking is al-
ready known (Abd-El-Barr et al., 2007). Moreover, the Cep290−/−
mouse model of LCA was also shown to present ER stress similar to the
BBS models showing a possible common mechanism for the RD.
Bbs10−/− and Cep290−/− show a decrease of the diﬀerent retinal
layers at 14 days depicting nuclei loss; with a more signiﬁcant decrease
in Bbs10−/− compared to Cep290−/−. This more aggressive BBS phe-
notype correlates with a signiﬁcant drop in nuclear count compared to a
smaller drop in Cep290. On the other hand, the related phenotype in
ALMS model seems UPR unrelated as no upregulation of key players for
UPR was observed. Other recent studies suggested that retinopathy in
Fig. 4. Ultrastructure of retinas and pathogenic genes expression in 7-week-old Alms1foz/foz mice retinas.
A) T.E.M. of 7-week-old Alms1 mice retina (n= 3) (Scale bar: 2 μm), asterisks indicate the presence of vacuoles in the IS cytoplasm CC: Connecting Cilium; B)
Immunoﬂuorescence of localization of rhodopsin (red) and counterstained nuclei in DAPI at 7-week-old on Alms1 mice retina. (n= 3) (Scale bar: 40 μm). OS: Outer
Segment: IS: Inner segment, ONL: Outer Nuclear Layer, INL: Inner Nuclear Layer; C) ER stress genes expressions in 7 week-old Alms1 mice retina (n=3). D) Alms1
gene expression in shRNA treated retinal explants (n = 3), *: P ≤ 0.05. E) Stress genes NFE in Alms1 shRNA treated retinal explants (n = 3), *: P ≤ 0.05. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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the Alström syndrome might be linked to a defect in the photo-
transduction cascade (Hostelley et al., 2016). Indeed the related genes
were upregulated in embryos of Alms1 mutant zebraﬁsh, while this was
not signiﬁcant in BBS1 mutant zebraﬁsh (Hostelley et al., 2016). We
also showed that while all retina layers are decreased in the 14-day-old
Bbs10−/− and Cep290−/− mice, the INL is not decreased in the
Alms1foz/foz mice. It could be caused by a delay in the retinal degen-
eration and we may hypothesize that the INL will be decrease at a later
stage on the disease.
The results above further indicate that retinopathy in ciliopathies
may be caused by diﬀerent mechanisms albeit they exhibit similarity
and overlap of retinal phenotypes, and clinical intervention in the fu-
ture should be given based on precise mechanism dissection. It is
known that the retinal phenotypes of ciliopathies show large hetero-
geneity within the same diseases (Scheidecker et al., 2015). For ex-
ample, it is well known that the BBS syndrome is a genetically het-
erogeneous disease. Clinical observation showed that BBS1 patients
display a milder and a relatively slower rate of retinal degeneration
than that caused by other BBS gene mutations (Daniels et al., 2012); an
hypothesis that is supported by the fact that Bbs1M390R/M390R knock-in
mice exhibit a relatively slow rate of retinal degeneration compared to
other BBS mice models (Cognard et al., 2015; Davis et al., 2007; Mockel
et al., 2012). For the LCA, the retinal phenotypes of mouse models of
LCA caused by diﬀerent mutations in diﬀerent genes (not all associated
with ciliopathies) showed large variability in the onset and the courses
of diseases, the manifestations of retinal fundus, the pattern of dys-
trophy (cone-rod dystrophy or rod-cone dystrophy).
The major ﬁndings here suggest that it is likely to develop a
common therapeutic strategy for retinal dystrophy when ER stress is
present, regardless of the causing mutation. In our previous research we
demonstrated that treatment targeted at ER stress using GIVin could
rescue retinal function and retinal morphology in Bbs12−/− mice
(Mockel et al., 2012). Other studies have also aimed at developing
treatment options for common processes instead of targeting directly
the defective gene, this is the case of tauroursodeoxycholic acid
(TUDCA) or antioxidants (Drack et al., 2012; Komeima et al., 2007).
The vast heterogeneity of the mutations causing RP coupled with the
fact that there is not always a proper genetic diagnostic for all the pa-
tients make targeted gene therapy a diﬃcult approach. Therefore, the
study and development of drugs that can be used in several RP causing
situations might be the best option for maintaining PR function for as
long as possible, creating a wider therapeutic window for the use of
speciﬁc treatments for the causing mutations or allowing a better ge-
netic diagnosis in patients with uncommon mutations where the
causing defect has not been determined.
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